NASDAQ:CLOV Clover Health Investments (CLOV) Stock Forecast, Price & News $1.03 +0.15 (+17.05%) (As of 06/5/2023 ET) Add Compare Share Share Today's Range$0.88▼$1.0450-Day Range$0.73▼$1.0752-Week Range$0.71▼$3.55Volume10.25 million shsAverage Volume6.77 million shsMarket Capitalization$497.13 millionP/E RatioN/ADividend YieldN/APrice Target$2.08 ProfileProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesSEC FilingsShort InterestSocial MediaProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesSEC FilingsShort InterestSocial Media Clover Health Investments MarketRank™ ForecastAnalyst RatingHold2.00 Rating ScoreUpside/Downside102.3% Upside$2.08 Price TargetShort InterestHealthy7.78% of Shares Sold ShortDividend StrengthN/ASustainabilityN/ANews SentimentN/AInsider TradingN/AProj. Earnings GrowthGrowingFrom ($0.63) to ($0.39) Per ShareSee Full Details Hide Full Details Overall MarketRank™MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.1.66 out of 5 starsMedical Sector824th out of 986 stocksHospital & Medical Service Plans Industry11th out of 11 stocks 3.0 Analyst's Opinion Consensus RatingClover Health Investments has received a consensus rating of Hold. The company's average rating score is 2.00, and is based on 1 buy rating, 2 hold ratings, and 1 sell rating.Price Target Upside/DownsideAccording to analysts' consensus price target of $2.08, Clover Health Investments has a forecasted upside of 102.3% from its current price of $1.03.Amount of Analyst CoverageClover Health Investments has received no research coverage in the past 90 days. Previous Next 3.0 Short Interest Percentage of Shares Shorted7.78% of the outstanding shares of Clover Health Investments have been sold short.Short Interest Ratio / Days to CoverClover Health Investments has a short interest ratio ("days to cover") of 5.6.Change versus previous monthShort interest in Clover Health Investments has recently decreased by 5.70%, indicating that investor sentiment is improving significantly. Previous Next 0.0 Dividend Strength Dividend YieldClover Health Investments does not currently pay a dividend.Dividend GrowthClover Health Investments does not have a long track record of dividend growth. Previous Next N/A Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThere is no current Upright™ data available for CLOV. Previous Next 0.0 News and Social Media Coverage News Coverage This WeekMarketBeat has tracked 1 news article for Clover Health Investments this week, compared to 2 articles on an average week.Search InterestOnly 52 people have searched for CLOV on MarketBeat in the last 30 days. This is a decrease of -47% compared to the previous 30 days.MarketBeat FollowsOnly 4 people have added Clover Health Investments to their MarketBeat watchlist in the last 30 days. This is a decrease of -50% compared to the previous 30 days. Previous Next 1.7 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Clover Health Investments insiders have not sold or bought any company stock.Percentage Held by Insiders21.42% of the stock of Clover Health Investments is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by InstitutionsOnly 29.79% of the stock of Clover Health Investments is held by institutions. Previous Next 0.6 Earnings and Valuation Earnings GrowthEarnings for Clover Health Investments are expected to grow in the coming year, from ($0.63) to ($0.39) per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Clover Health Investments is -1.45, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Clover Health Investments is -1.45, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioClover Health Investments has a P/B Ratio of 1.41. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities. Previous Next See Top Rated MarketRank™ Stocks Here About Clover Health Investments (NASDAQ:CLOV) StockClover Health Investments, Corp. operates as a medicare advantage insurer in the United States. The company through its Clover Assistant, a software platform that provides preferred provider organization and health maintenance organization health plans for medicare-eligible consumers. It also focuses on non-insurance businesses. Clover Health Investments, Corp. was incorporated in 2014 and is based in Franklin, Tennessee.Read More Receive CLOV Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Clover Health Investments and its competitors with MarketBeat's FREE daily newsletter. Email Address CLOV Stock News HeadlinesMay 31, 2023 | fool.comClover Health Investments, Corp. (NASDAQ: CLOV)May 19, 2023 | finance.yahoo.comIs Clover Health Investments (CLOV) Stock Outpacing Its Medical Peers This Year?June 5, 2023 | Behind the Markets (Ad)66,000% upside on tiny biotech?The Wall Street Journal reports that this medical breakthrough is "Transforming Medicine." One analyst calculated that it could be worth $1 Trillion, making the upside potential of this small-cap 66,000% above today's price.May 16, 2023 | msn.comClover Health Investments: A Reassuring Business Model And Future ProspectsMay 16, 2023 | americanbankingnews.comQ3 2023 EPS Estimates for Clover Health Investments, Corp. Boosted by Analyst (NASDAQ:CLOV)May 15, 2023 | americanbankingnews.comClover Health Investments (NASDAQ:CLOV) Price Target Cut to $1.00May 15, 2023 | seekingalpha.comClover Health: Strategic Refocus After Learning From Previous MisstepsMay 13, 2023 | marketwatch.comClover Health Investments Corp. Class A $CLOV Pivots Trading Plans and Risk ControlsJune 5, 2023 | Behind the Markets (Ad)66,000% upside on tiny biotech?The Wall Street Journal reports that this medical breakthrough is "Transforming Medicine." One analyst calculated that it could be worth $1 Trillion, making the upside potential of this small-cap 66,000% above today's price.May 12, 2023 | finance.yahoo.comAnalyst Estimates: Here's What Brokers Think Of Clover Health Investments, Corp. (NASDAQ:CLOV) After Its First-Quarter ReportMay 10, 2023 | finance.yahoo.comClover Health Investments, Corp. (NASDAQ:CLOV) Q1 2023 Earnings Call TranscriptMay 10, 2023 | finanznachrichten.deClover Health Investments, Corp.: Clover Health Reports First Quarter 2023 Financial ResultsMay 10, 2023 | finance.yahoo.comQ1 2023 Clover Health Investments Corp Earnings CallMay 10, 2023 | markets.businessinsider.comWhat's Going On With Clover Health Stock Wednesday?May 10, 2023 | seekingalpha.comClover Health Investments improves 2023 guidanceMay 9, 2023 | finance.yahoo.comClover Health Reports First Quarter 2023 Financial ResultsMay 7, 2023 | americanbankingnews.comClover Health Investments (CLOV) Scheduled to Post Quarterly Earnings on TuesdayMay 4, 2023 | finance.yahoo.comClover Health to Present at Bank of America 2023 Healthcare Conference on May 11, 2023May 4, 2023 | marketwatch.comClover Health Investments Corp. Class A ($CLOV) Trading ReportApril 27, 2023 | finance.yahoo.comClover Health Investments (NASDAQ:CLOV shareholders incur further losses as stock declines 10% this week, taking one-year losses to 72%April 24, 2023 | seekingalpha.comClover Health settles class action securities lawsuit for $22MApril 24, 2023 | finance.yahoo.comClover Health Announces Agreement to Settle Securities Class Action LitigationApril 22, 2023 | americanbankingnews.comClover Health Investments, Corp. (NASDAQ:CLOV) Short Interest Up 12.3% in MarchApril 17, 2023 | marketwatch.comClover Health Cuts 10% of Workforce Amid RestructuringApril 17, 2023 | finance.yahoo.comClover Health Announces Business Transformation Initiatives to Accelerate Path to ProfitabilityApril 11, 2023 | finance.yahoo.comClover Health to Report First Quarter 2023 Financial Results on May 9, 2023March 31, 2023 | finance.yahoo.comWill Clover Health Investments (NASDAQ:CLOV) Spend Its Cash Wisely?See More Headlines CLOV Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart CLOV Company Calendar Today6/05/2023Next Earnings (Estimated)8/14/2023Fiscal Year End12/31/2023Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ Industry Hospital & medical service plans Sub-IndustryN/A SectorMedical Current SymbolNASDAQ:CLOV CUSIPN/A CIK1801170 Webwww.cloverhealth.com Phone201-432-2133FaxN/AEmployees680Year FoundedN/APrice Target and Rating Average Stock Price Forecast$2.08 High Stock Price Forecast$4.00 Low Stock Price Forecast$1.00 Forecasted Upside/Downside+104.2%Consensus RatingHold Rating Score (0-4)2.00 Research Coverage4 Analysts Profitability EPS (Most Recent Fiscal Year)($0.71) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-338,840,000.00 Net Margins-10.74% Pretax Margin-10.73% Return on Equity-96.52% Return on Assets-24.44% Debt Debt-to-Equity RatioN/A Current Ratio1.15 Quick Ratio1.15 Sales & Book Value Annual Sales$3.48 billion Price / Sales0.14 Cash FlowN/A Price / Cash FlowN/A Book Value$0.73 per share Price / Book1.40Miscellaneous Outstanding Shares482,650,000Free Float379,270,000Market Cap$492.30 million OptionableNot Optionable Beta1.97 Key ExecutivesMr. Vivek Garipalli (Age 44)Co-Founder & Chairman Of Board Mr. Andrew Toy (Age 43)Co-Founder, CEO & Director Comp: $537.89kMs. Jamie L. Reynoso (Age 53)Chief Operating Officer Comp: $461.74kMr. Prabhdeep Singh (Age 38)Chief Growth Officer Comp: $399.14kMr. Scott J. Leffler (Age 48)Chief Financial Officer Mr. Conrad WaiChief Technology OfficerMr. Derrick L. NuemanHead of Investor Relations & Corp. strategyMs. Wendy RicheyChief Compliance OfficerMr. Joseph Richards Martin (Age 46)Gen. Counsel & Corp. Sec. Ms. Rachel FishChief People OfficerMore ExecutivesKey CompetitorsAlignment HealthcareNASDAQ:ALHCEmergent BioSolutionsNYSE:EBSOmega TherapeuticsNASDAQ:OMGAMaxCyteNASDAQ:MXCTAllakosNASDAQ:ALLKView All CompetitorsInstitutional OwnershipJPMorgan Chase & Co.Bought 92,006 shares on 5/18/2023Ownership: 0.096%New York State Common Retirement FundSold 74,700 shares on 5/18/2023Ownership: 0.048%State Street CorpSold 30,826 shares on 5/16/2023Ownership: 1.838%Jane Street Group LLCBought 23,200 shares on 5/16/2023Ownership: 0.000%Skaana Management L.P.Sold 29,700 shares on 5/16/2023Ownership: 0.000%View All Institutional Transactions CLOV Stock - Frequently Asked Questions Should I buy or sell Clover Health Investments stock right now? 4 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Clover Health Investments in the last twelve months. There are currently 1 sell rating, 2 hold ratings and 1 buy rating for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" CLOV shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in CLOV, but not buy additional shares or sell existing shares. View CLOV analyst ratings or view top-rated stocks. What is Clover Health Investments' stock price forecast for 2023? 4 analysts have issued twelve-month price targets for Clover Health Investments' stock. Their CLOV share price forecasts range from $1.00 to $4.00. On average, they expect the company's share price to reach $2.08 in the next twelve months. This suggests a possible upside of 104.2% from the stock's current price. View analysts price targets for CLOV or view top-rated stocks among Wall Street analysts. How have CLOV shares performed in 2023? Clover Health Investments' stock was trading at $0.9295 at the start of the year. Since then, CLOV shares have increased by 9.7% and is now trading at $1.02. View the best growth stocks for 2023 here. Are investors shorting Clover Health Investments? Clover Health Investments saw a drop in short interest during the month of May. As of May 15th, there was short interest totaling 37,550,000 shares, a drop of 5.7% from the April 30th total of 39,820,000 shares. Based on an average daily volume of 6,700,000 shares, the days-to-cover ratio is currently 5.6 days. View Clover Health Investments' Short Interest. When is Clover Health Investments' next earnings date? The company is scheduled to release its next quarterly earnings announcement on Monday, August 14th 2023. View our CLOV earnings forecast. What ETFs hold Clover Health Investments' stock? ETFs with the largest weight of Clover Health Investments (NASDAQ:CLOV) stock in their portfolio include SPDR S&P Health Care Services ETF (XHS), Janus Henderson Small Cap Growth Alpha ETF (JSML), Janus Henderson Small/Mid Cap Growth Alpha ETF (JSMD), iShares U.S. Healthcare Providers ETF (IHF), What guidance has Clover Health Investments issued on next quarter's earnings? Clover Health Investments updated its FY 2023 earnings guidance on Tuesday, May, 9th. The company provided earnings per share guidance of for the period. The company issued revenue guidance of $1.93 billion-$2.03 billion, compared to the consensus revenue estimate of $1.95 billion. What is Clover Health Investments' stock symbol? Clover Health Investments trades on the NASDAQ under the ticker symbol "CLOV." Who are Clover Health Investments' major shareholders? Clover Health Investments' stock is owned by many different institutional and retail investors. Top institutional investors include BlackRock Inc. (5.55%), State Street Corp (1.84%), Geode Capital Management LLC (1.44%), Renaissance Technologies LLC (1.43%), Charles Schwab Investment Management Inc. (0.50%) and Susquehanna International Group LLP (0.00%). Insiders that own company stock include Chamath Palihapitiya, Chelsea Clinton and Lee Shapiro. View institutional ownership trends. How do I buy shares of Clover Health Investments? Shares of CLOV stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here. What is Clover Health Investments' stock price today? One share of CLOV stock can currently be purchased for approximately $1.02. How much money does Clover Health Investments make? Clover Health Investments (NASDAQ:CLOV) has a market capitalization of $492.30 million and generates $3.48 billion in revenue each year. The company earns $-338,840,000.00 in net income (profit) each year or ($0.71) on an earnings per share basis. How many employees does Clover Health Investments have? The company employs 680 workers across the globe. How can I contact Clover Health Investments? Clover Health Investments' mailing address is 317 University Ave Suite 200, Palo Alto CA, 94301. The official website for the company is www.cloverhealth.com. The company can be reached via phone at 201-432-2133 or via email at investors@cloverhealth.com. This page (NASDAQ:CLOV) was last updated on 6/5/2023 by MarketBeat.com Staff Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Clover Health Investments, Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.